| Previous Close | 27.10 |
| Open | 27.04 |
| Bid | 28.30 x 3200 |
| Ask | 28.34 x 800 |
| Day's Range | 27.04 - 28.50 |
| 52 Week Range | 20.03 - 54.97 |
| Volume | 142,241 |
| Avg. Volume | 344,227 |
| Market Cap | 1.055B |
| Beta (5Y Monthly) | 0.94 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.64 |
| Earnings Date | Nov. 03, 2020 - Nov. 09, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 61.00 |
- Simply Wall St.
How Does REGENXBIO's (NASDAQ:RGNX) CEO Salary Compare to Peers?
Ken Mills became the CEO of REGENXBIO Inc. (NASDAQ:RGNX) in 2009, and we think it's a good time to look at the...
- Zacks
Regenxbio (RGNX) Reports Q2 Loss, Lags Revenue Estimates
Regenxbio (RGNX) delivered earnings and revenue surprises of -2.25% and -14.56%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
Analysts Estimate Regenxbio (RGNX) to Report a Decline in Earnings: What to Look Out for
Regenxbio (RGNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2020 Verizon Media. All rights reserved.
